| Lastest Insider Transactions Of Taysha Gene Therapies, Inc. ( TSHA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2026-07-10 | Sell | 200,000 | 6.24 | 1,248,000 | 2026-07-10 18:54:36 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2026-04-10 | Sell | 200,000 | 4.46 | 892,000 | 2026-04-13 16:33:58 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2026-04-10 | Option Exercise | 19,021 | 1.71 | 32,526 | 2026-04-13 16:33:58 |
| TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CHIEF FINANCIAL OFFICER | 2026-02-04 | Sell | 1,655 | 4.52 | 7,481 | 2026-02-06 16:30:29 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2026-01-23 | Sell | 116,050 | 4.72 | 547,469 | 2026-01-27 16:05:16 |
| TSHA | Taysha Gene Therapies, Inc. | Nolan Sean P. | Chief Executive Officer | 2026-01-23 | Sell | 178,101 | 4.72 | 840,196 | 2026-01-27 16:05:07 |
| TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CHIEF FINANCIAL OFFICER | 2026-01-23 | Sell | 102,817 | 4.72 | 485,042 | 2026-01-27 16:05:05 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2026-01-12 | Sell | 200,000 | 4.71 | 942,000 | 2026-01-14 16:45:07 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2026-01-12 | Option Exercise | 200,000 | 1.15 | 229,440 | 2026-01-14 16:45:07 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2025-11-28 | Sell | 370,172 | 4.58 | 1,695,906 | 2025-12-01 20:58:44 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2025-11-28 | Option Exercise | 370,172 | 1.52 | 562,043 | 2025-12-01 20:58:44 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2025-09-10 | Sell | 200,000 | 3.23 | 646,000 | 2025-09-12 16:15:25 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2025-09-10 | Option Exercise | 41,150 | 0.70 | 28,760 | 2025-09-12 16:15:25 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2025-08-21 | Sell | 57,054 | 2.85 | 162,604 | 2025-08-22 16:15:17 |
| TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CHIEF FINANCIAL OFFICER | 2025-08-21 | Sell | 54,491 | 2.85 | 155,299 | 2025-08-22 16:15:08 |
| TSHA | Taysha Gene Therapies, Inc. | Manning Paul B | 10% Owner | 2025-05-30 | Buy | 750,000 | 2.75 | 2,062,500 | 2025-06-03 21:38:27 |
| TSHA | Taysha Gene Therapies, Inc. | Manning Paul B | 10% Owner | 2024-06-27 | Buy | 1,333,333 | 2.25 | 2,999,999 | 2024-07-01 08:00:07 |
| TSHA | Taysha Gene Therapies, Inc. | Manning Paul B | 10% Owner | 2023-11-17 | Buy | 100,000 | 1.63 | 163,000 | 2023-11-20 07:35:02 |
| TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | 2023-08-24 | Sell | 33,000 | 2.33 | 76,890 | 2023-08-25 16:30:47 |
| TSHA | Taysha Gene Therapies, Inc. | Manning Paul B | 10% Owner | 2023-08-16 | Buy | 16,466,667 | 0.90 | 14,820,000 | 2023-08-16 20:57:08 |
| TSHA | Taysha Gene Therapies, Inc. | Stalfort John A III | Directior | 2023-08-16 | Buy | 777,778 | 0.90 | 700,000 | 2023-08-16 20:53:51 |
| TSHA | Taysha Gene Therapies, Inc. | Nolan Sean P. | Chief Executive Officer | 2023-08-16 | Buy | 444,444 | 0.90 | 400,000 | 2023-08-16 20:52:21 |
| TSHA | Taysha Gene Therapies, Inc. | Donenberg Phillip B. | Directior | 2023-08-16 | Buy | 111,111 | 0.90 | 100,000 | 2023-08-16 20:51:19 |
| TSHA | Taysha Gene Therapies, Inc. | Session R.A. II | 10% Owner | 2023-07-12 | Sell | 85,872 | 0.71 | 60,771 | 2023-07-14 16:00:39 |
| TSHA | Taysha Gene Therapies, Inc. | Session R.A. II | 10% Owner | 2023-06-22 | Sell | 28,608 | 0.70 | 20,119 | 2023-06-26 16:46:19 |
| TSHA | Taysha Gene Therapies, Inc. | Session R.A. II | 10% Owner | 2023-06-20 | Sell | 434,615 | 0.71 | 307,844 | 2023-06-22 16:00:11 |
| TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | President and Head of R&D | 2023-05-16 | Buy | 5,000 | 0.68 | 3,400 | 2023-05-18 16:44:26 |